These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 29511827)

  • 1. Impulse control disorders in Parkinson's disease.
    Marques A; Durif F; Fernagut PO
    J Neural Transm (Vienna); 2018 Aug; 125(8):1299-1312. PubMed ID: 29511827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and clinical characteristics of hypersexuality in patients with Parkinson's disease following dopaminergic therapy: A systematic literature review.
    Nakum S; Cavanna AE
    Parkinsonism Relat Disord; 2016 Apr; 25():10-6. PubMed ID: 26923525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.
    Voon V; Napier TC; Frank MJ; Sgambato-Faure V; Grace AA; Rodriguez-Oroz M; Obeso J; Bezard E; Fernagut PO
    Lancet Neurol; 2017 Mar; 16(3):238-250. PubMed ID: 28229895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
    Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
    Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list.
    Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E
    Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
    Wolters ECh; van der Werf YD; van den Heuvel OA
    J Neurol; 2008 Sep; 255 Suppl 5():48-56. PubMed ID: 18787882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypersexuality and other impulse control disorders in Parkinson's disease].
    Nelis EA; Berendse HW; van den Heuvel OA
    Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.
    Kraemmer J; Smith K; Weintraub D; Guillemot V; Nalls MA; Cormier-Dequaire F; Moszer I; Brice A; Singleton AB; Corvol JC
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1106-11. PubMed ID: 27076492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
    Bienfait KL; Menza M; Mark MH; Dobkin RD
    J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risky business of dopamine agonists in Parkinson disease and impulse control disorders.
    Claassen DO; van den Wildenberg WPM; Ridderinkhof KR; Jessup CK; Harrison MB; Wooten GF; Wylie SA
    Behav Neurosci; 2011 Aug; 125(4):492-500. PubMed ID: 21604834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impulsive-compulsive syndrome in Parkinson's disease].
    Nikitina AV; Fedorova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
    Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC
    Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
    Seeman P
    Synapse; 2015 Apr; 69(4):183-9. PubMed ID: 25645960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.
    Smith KM; Xie SX; Weintraub D
    J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):864-70. PubMed ID: 26534930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease].
    Sáez-Francàs N; Martí Andrés G; Ramírez N; de Fàbregues O; Álvarez-Sabín J; Casas M; Hernández-Vara J
    Neurologia; 2016 May; 31(4):231-8. PubMed ID: 26096669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis.
    Antonini A; Chaudhuri KR; Boroojerdi B; Asgharnejad M; Bauer L; Grieger F; Weintraub D
    Eur J Neurol; 2016 Oct; 23(10):1556-65. PubMed ID: 27425586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.